{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:04:23Z","timestamp":1780369463595,"version":"3.54.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T00:00:00Z","timestamp":1569715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"publisher","award":["60\u2013073"],"award-info":[{"award-number":["60\u2013073"]}],"id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Increasing awareness of and understanding about antimicrobial resistance (AMR), promoting changes in behavior, and monitoring of AMR in the community are challenging, as AMR is associated with many contributing factors that are difficult to assess individually. This study aimed to determine the effectiveness of a community-based AMR campaign for improving awareness, understanding, and behavior relating to antibiotic use and AMR in Thailand and to assess if fecal carriage of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae could be a proxy composite indicator of AMR in the community.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was conducted in 4 communities that are home to approximately 400 000 people. A self-administered questionnaire on awareness, understanding, and behavior relating to antibiotic use and AMR was responded to by 20 521 and 19 634 adults before and immediately after the AMR campaign, respectively, at the household level. Fecal samples were collected from 534 adults before the AMR campaign and from 709 adults at 18 months after the AMR campaign to determine presence of ESBL-producing Enterobacteriaceae.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Awareness, understanding, and behavior relating to antibiotic use and AMR, as assessed by a self-administered questionnaire, were significantly improved after the AMR campaign. The fecal carriage rate of ESBL-producing Enterobacteriaceae decreased from 66.5% before to 44.6% after the AMR campaign (P &amp;lt; .01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our AMR campaign was effective for improving awareness, understanding, and behavior relating to antibiotic use and AMR among people in the community at the household level, and the prevalence of fecal carriage of ESBL-producing Enterobacteriaceae seemed to be decreased after the AMR campaign. Fecal carriage rate of ESBL-producing Enterobacteriaceae may be a proxy composite indicator of AMR in the community.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ofid\/ofz425","type":"journal-article","created":{"date-parts":[[2019,9,29]],"date-time":"2019-09-29T19:02:32Z","timestamp":1569783752000},"source":"Crossref","is-referenced-by-count":10,"title":["Fecal Carriage Rate of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae as a Proxy Composite Indicator of Antimicrobial Resistance in a Community in Thailand"],"prefix":"10.1093","volume":"6","author":[{"given":"Visanu","family":"Thamlikitkul","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerawit","family":"Tangkoskul","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chakkraphong","family":"Seenama","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Tropical Medicine, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"2020081005080266100_CIT0001","volume-title":"Tackling Drug-Resistant Infections Globally: Final Report and Recommendations","author":"O\u2019Neill","year":"2016"},{"key":"2020081005080266100_CIT0002","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03009734.2016.1195900","article-title":"Antimicrobial resistance\u2014a threat to the world\u2019s sustainable development","volume":"121","author":"Jasovsk\u00fd","year":"2016","journal-title":"Ups J Med Sci"},{"key":"2020081005080266100_CIT0003","first-page":"338","article-title":"Health and economic impacts of antimicrobial resistant infections in Thailand: a preliminary study","volume":"6","author":"Phumart","year":"2012","journal-title":"J Health Systems Research"},{"key":"2020081005080266100_CIT0004","doi-asserted-by":"crossref","first-page":"e18082","DOI":"10.7554\/eLife.18082","article-title":"Epidemiology and burden of multidrug-resistant bacterial infection in a developing country","volume":"5","author":"Lim","year":"2016","journal-title":"Elife"},{"key":"2020081005080266100_CIT0005","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1017\/S0950268818003436","article-title":"Annual relative increased in inpatient mortality from antimicrobial resistant nosocomial infections in Thailand","volume":"147","author":"Phodha","year":"2019","journal-title":"Epidemiol Infect"},{"key":"2020081005080266100_CIT0006","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14737167.2019.1537123","article-title":"Excess annual economic burdens from nosocomial infections caused by multi-drug resistant bacteria in Thailand","volume":"19","author":"Phodha","year":"2019","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"2020081005080266100_CIT0007","volume-title":"Global Action Plan on Antimicrobial Resistance","author":"World Health Organization","year":"2015"},{"key":"2020081005080266100_CIT0008","doi-asserted-by":"crossref","first-page":"e54714","DOI":"10.1371\/journal.pone.0054714","article-title":"Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study","volume":"8","author":"Kanoksil","year":"2013","journal-title":"PLoS One"},{"key":"2020081005080266100_CIT0009","first-page":"1172","article-title":"A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria","volume":"91","author":"Suankratay","year":"2008","journal-title":"J Med Assoc Thai"},{"key":"2020081005080266100_CIT0010","doi-asserted-by":"crossref","first-page":"e0190132","DOI":"10.1371\/journal.pone.0190132","article-title":"Implementation of global antimicrobial resistance surveillance system (GLASS) in patients with bacteremia","volume":"13","author":"Sirijatuphat","year":"2018","journal-title":"PLoS One"},{"key":"2020081005080266100_CIT0011","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1128\/JCM.01008-08","article-title":"High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients","volume":"46","author":"Valverde","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2020081005080266100_CIT0012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s15010-011-0128-2","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli strains in the feces of carriers contribute substantially to urinary tract infections in these patients","volume":"39","author":"Niki","year":"2011","journal-title":"Infection"},{"key":"2020081005080266100_CIT0013","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s10096-018-3275-x","article-title":"Subsequent infection with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in patients with prior infection or fecal colonization","volume":"37","author":"Lindblom","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020081005080266100_CIT0014","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1128\/CMR.00023-13","article-title":"Trends in human fecal carriage of extended-spectrum \u03b2-lactamases in the community: toward the globalization of CTX-M","volume":"26","author":"Woerther","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"2020081005080266100_CIT0015","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/jmm.0.026955-0","article-title":"Analysis of risk factors for a high prevalence of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand","volume":"60","author":"Luvsansharav","year":"2011","journal-title":"J Med Microbiol"},{"key":"2020081005080266100_CIT0016","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/jac\/dks118","article-title":"Prevalence of and risk factors associated with faecal carriage of CTX-M \u03b2-lactamase-producing Enterobacteriaceae in rural Thai communities","volume":"67","author":"Luvsansharav","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2020081005080266100_CIT0017","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1179\/2047773214Y.0000000148","article-title":"Prevalence of antibiotic resistant bacteria in healthy adults, foods, food animals, and the environment in selected areas in Thailand","volume":"108","author":"Boonyasiri","year":"2014","journal-title":"Pathog Glob Health"},{"key":"2020081005080266100_CIT0018","first-page":"270","article-title":"Epidemiology of antibiotic use and antimicrobial resistance in selected communities in Thailand","volume":"99","author":"Khamsarn","year":"2016","journal-title":"J Med Assoc Thai"},{"key":"2020081005080266100_CIT0019","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s10096-010-1031-y","article-title":"Colonisation with Escherichia coli resistant to \u201ccritically important\u201d antibiotics: a high risk for international travellers","volume":"29","author":"Kennedy","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020081005080266100_CIT0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tmaid.2013.06.004","article-title":"Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study","volume":"11","author":"Lausch","year":"2013","journal-title":"Travel Med Infect Dis"},{"key":"2020081005080266100_CIT0021","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1908.130257","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae among travelers from the Netherlands","volume":"19","author":"Paltansing","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"2020081005080266100_CIT0022","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/jac\/dkt167","article-title":"Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors","volume":"68","author":"Ostholm-Balkhed","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"2020081005080266100_CIT0023","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijmm.2014.12.001","article-title":"Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany","volume":"305","author":"L\u00fcbbert","year":"2015","journal-title":"Int J Med Microbiol"},{"key":"2020081005080266100_CIT0024","doi-asserted-by":"crossref","first-page":"252.e1","DOI":"10.1016\/j.cmi.2014.09.021","article-title":"CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives","volume":"21","author":"Valverde","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2020081005080266100_CIT0025","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/cid\/civ333","article-title":"High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics","volume":"61","author":"Rupp\u00e9","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020081005080266100_CIT0026","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1473-3099(16)30319-X","article-title":"Import and spread of extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study","volume":"17","author":"Arcilla","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2020081005080266100_CIT0027","doi-asserted-by":"crossref","first-page":"e0193834","DOI":"10.1371\/journal.pone.0193834","article-title":"Time to acquire and lose carriership of ESBL\/pAmpC producing E. coli in humans in the Netherlands","volume":"13","author":"Teunis","year":"2018","journal-title":"PLoS One"},{"key":"2020081005080266100_CIT0028","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/00365548.2011.653582","article-title":"Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers\u2019 diarrhoea","volume":"44","author":"Tham","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"2020081005080266100_CIT0029","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1469-0691.2007.01846.x","article-title":"Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide","volume":"14","author":"Drieux","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"2020081005080266100_CIT0030","doi-asserted-by":"crossref","first-page":"e001315","DOI":"10.1136\/bmjgh-2018-001315","article-title":"Tracking global trends in the effectiveness of antibiotic therapy using the drug resistance index","volume":"4","author":"Klein","year":"2019","journal-title":"BMJ Glob Health"},{"key":"2020081005080266100_CIT0031","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2334-13-199","article-title":"Frequency and factors associated with carriage of multi-drug resistant commensal Escherichia coli among women attending antenatal clinics in central India","volume":"13","author":"Pathak","year":"2013","journal-title":"BMC Infect Dis"},{"key":"2020081005080266100_CIT0032","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jac\/dkv021","article-title":"Colonization with Enterobacteriaceae producing ESBLs in children attending pre-school childcare facilities in the Lao People\u2019s Democratic Republic","volume":"70","author":"Stoesser","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020081005080266100_CIT0033","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12941-016-0121-9","article-title":"Prevalence and characterization of extended-spectrum beta-lactamases producing Enterobacteriaceae in healthy children and associated risk factors","volume":"15","author":"Hijazi","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2020081005080266100_CIT0034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tmaid.2017.01.003","article-title":"Fluoroquinolone antibiotic users select fluoroquinolone-resistant ESBL-producing Enterobacteriaceae (ESBL-PE) - data of a prospective traveller study","volume":"16","author":"Kantele","year":"2017","journal-title":"Travel Med Infect Dis"},{"key":"2020081005080266100_CIT0035","doi-asserted-by":"crossref","first-page":"e0200894","DOI":"10.1371\/journal.pone.0200894","article-title":"Prevalence and risk factors for faecal carriage of extended spectrum \u03b2-lactamase producing Enterobacteriaceae among food handlers in lower basic schools in West Coast Region of the Gambia","volume":"13","author":"Sanneh","year":"2018","journal-title":"PLoS One"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofz425\/30074036\/ofz425.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/10\/ofz425\/33599085\/ofz425.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/10\/ofz425\/33599085\/ofz425.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T08:28:33Z","timestamp":1664526513000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz425\/5575988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,30]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz425","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,9,30]]},"article-number":"ofz425"}}